In the MP-treated Lep KO mice of this study, the number of lipid droplets, NAFLD score and steatosis area were significantly reduced, contrary to expectations although the enhancements of them were detected in MP-treated WT mice [21]. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.